This is a news story, published by Sky News, that relates primarily to the University of Southampton news.
For more vaccine development news, you can click here:
more vaccine development newsFor more news from Sky News, you can click here:
more news from Sky NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
new diagnostic tool. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest blood test news, early cancer diagnosis news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
medical technologySky News
•
84% Informative
Academics from the University of Southampton will lead a team working on the new diagnostic tool.
It is one of a series of innovations that could share public and private sector investment worth 148 m.
Others may include cheaper scanners that help to detect early signs of cancer, and artificial intelligence to diagnose cancer through data shared across NHS .
VR Score
90
Informative language
91
Neutral language
84
Article tone
formal
Language
English
Language complexity
61
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links